You are here

  • Home
  • Archive
  • Volume 24, Issue 7
  • Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model

Article metrics

Article menu
Download PDFPDF
Basic Science
Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model

 

Online download statistics by month:

Online download statistics by month: February 2019 to April 2024

AbstractFullPdf
Feb 2019600
Mar 20193803
Apr 20192700
May 20195702
Jun 20194800
Jul 20195703
Aug 20199000
Sep 20195700
Oct 20199900
Nov 20197502
Dec 201911201
Jan 20207903
Feb 20206901
Mar 202010100
Apr 20207500
May 20207003
Jun 20206705
Jul 20204200
Aug 20204300
Sep 20205900
Oct 20204302
Nov 20209100
Dec 20205601
Jan 20218302
Feb 20216700
Mar 202113900
Apr 20217901
May 20215900
Jun 2021504
Jul 2021100
Aug 2021200
Sep 2021101
Oct 202110102
Nov 202117204
Dec 202119503
Jan 202213302
Feb 202212103
Mar 202219301
Apr 20228902
May 202215108
Jun 202214302
Jul 202218303
Aug 202211305
Sep 202212002
Oct 202211203
Nov 20227702
Dec 20228401
Jan 20239901
Feb 202318203
Mar 202310700
Apr 20233305
May 20239801
Jun 202312201
Jul 20236500
Aug 20237501
Sep 20236400
Oct 20239404
Nov 202310201
Dec 202311201
Jan 20244200
Feb 20248100
Mar 202410503
Apr 20249602
Total53610100